Wright Medical Group NV (WMGI) Holdings Lowered by Gabelli Funds LLC

Gabelli Funds LLC lowered its position in shares of Wright Medical Group NV (NASDAQ:WMGI) by 15.8% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 471,000 shares of the medical device company’s stock after selling 88,500 shares during the quarter. Gabelli Funds LLC owned 0.44% of Wright Medical Group worth $13,668,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently bought and sold shares of WMGI. Amalgamated Bank raised its holdings in shares of Wright Medical Group by 14.9% in the 2nd quarter. Amalgamated Bank now owns 16,232 shares of the medical device company’s stock worth $421,000 after purchasing an additional 2,102 shares during the period. Rhumbline Advisers grew its stake in Wright Medical Group by 4.5% in the 2nd quarter. Rhumbline Advisers now owns 99,783 shares of the medical device company’s stock valued at $2,590,000 after buying an additional 4,294 shares in the last quarter. Strs Ohio grew its stake in Wright Medical Group by 850.0% in the 2nd quarter. Strs Ohio now owns 5,700 shares of the medical device company’s stock valued at $147,000 after buying an additional 5,100 shares in the last quarter. Principal Financial Group Inc. grew its stake in Wright Medical Group by 7.0% in the 1st quarter. Principal Financial Group Inc. now owns 92,781 shares of the medical device company’s stock valued at $1,841,000 after buying an additional 6,084 shares in the last quarter. Finally, Vishria Bird Financial Group LLC purchased a new position in Wright Medical Group in the 3rd quarter valued at approximately $214,000.

A number of research analysts recently weighed in on the stock. Robert W. Baird lifted their price objective on shares of Wright Medical Group from $28.00 to $32.00 and gave the company an “outperform” rating in a research note on Thursday, August 9th. Needham & Company LLC lifted their price objective on shares of Wright Medical Group from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, October 25th. Piper Jaffray Companies lifted their price objective on shares of Wright Medical Group to $35.00 and gave the company an “overweight” rating in a research note on Thursday. BMO Capital Markets upgraded shares of Wright Medical Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $28.00 to $31.00 in a research note on Wednesday, August 29th. Finally, BidaskClub upgraded shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research note on Tuesday, August 14th. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. Wright Medical Group currently has a consensus rating of “Buy” and a consensus target price of $32.75.

WMGI opened at $30.19 on Friday. The firm has a market cap of $2.93 billion, a PE ratio of -137.23 and a beta of 1.06. The company has a quick ratio of 1.57, a current ratio of 2.06 and a debt-to-equity ratio of 1.87. Wright Medical Group NV has a one year low of $19.01 and a one year high of $30.75.

Wright Medical Group (NASDAQ:WMGI) last released its quarterly earnings results on Wednesday, November 7th. The medical device company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.06. The firm had revenue of $194.11 million during the quarter, compared to analyst estimates of $186.09 million. Wright Medical Group had a negative net margin of 24.74% and a negative return on equity of 1.94%. The business’s revenue for the quarter was up 13.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.16) EPS. Sell-side analysts forecast that Wright Medical Group NV will post -0.15 EPS for the current fiscal year.

In other news, CFO Lance A. Berry sold 1,182 shares of the business’s stock in a transaction on Thursday, August 16th. The shares were sold at an average price of $27.19, for a total transaction of $32,138.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Peter Cooke sold 20,662 shares of the business’s stock in a transaction on Thursday, November 8th. The shares were sold at an average price of $29.28, for a total transaction of $604,983.36. The disclosure for this sale can be found here. Insiders have sold a total of 36,979 shares of company stock valued at $1,060,083 over the last 90 days. Company insiders own 4.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/11/10/wright-medical-group-nv-wmgi-holdings-lowered-by-gabelli-funds-llc.html.

Wright Medical Group Profile

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.

Featured Article: What is a Stop Order?

Institutional Ownership by Quarter for Wright Medical Group (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply